Joseph Berger
Psychiatry · Atlanta, GANPI 1164526117
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Ironshore Pharmaceuticals Inc. at 41.4% of the total. Reporting peaked in 2019 at $15,958 and has fallen 96.5% since, to $554 in 2025. Among psychiatry clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 148 payments — averaging $161.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$10K
- Takeda Pharmaceuticals U.S.A., Inc.$8K
- Johnson & Johnson$1K
- Otsuka America Pharmaceutical, Inc.$647
- Axsome Therapeutics, Inc.$645
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$600
- plus $2K from 18 others
Across 2 payments — averaging $1374.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- TG Therapeutics, Inc.$3K
What the payments were for
- Speaking & faculty fees$13,34356%
- Travel & lodging$3,76916%
- Food & beverage$6,78128%
- Education$30%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 27 | $9,899 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $8,210 |
| Johnson & Johnson | 21 | $1,492 |
| Otsuka America Pharmaceutical, Inc. | 11 | $647 |
| Axsome Therapeutics, Inc. | 8 | $645 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $600 |
| Corium, LLC | 4 | $384 |
| Lundbeck LLC | 19 | $347 |
| Tris Pharma Inc | 4 | $282 |
| AbbVie | 3 | $231 |
| Vanda Pharmaceuticals Inc. | 5 | $191 |
| Alkermes, Inc. | 2 | $130 |
| Teva Pharmaceuticals USA, Inc. | 2 | $129 |
| Luye Pharma (USA) Ltd. | 1 | $125 |
| Viiv Healthcare Company | 1 | $116 |
| Neurocrine Biosciences, Inc. | 1 | $107 |
| Supernus Pharmaceuticals, Inc. | 1 | $104 |
| Eisai Inc. | 1 | $95 |
| TG Therapeutics, Inc. | 1 | $69 |
| Shire North American Group Inc | 2 | $32 |
| Adlon Therapeutics L.p. | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$9,249
- VYVANSE$7,631
- SPRAVATO$576
- INVEGA SUSTENNA$505
- LYBALVI$480
- Auvelity$375
- Azstarys$360
- CAPLYTA$334
- Quillichew ER$246
- Dyanavel XR$246
- Quillivant$246
- REXULTI$222
- VRAYLAR$217
- ERZOFRI EXTENDED-RELEASE$125
- Fanapt$122
- AUSTEDO$117
- RUKOBIA$116
- INGREZZA$107
- QELBREE$104
How this compares
$23,897 in reported general payments places this provider in the 95th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 38 | $2,845 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 25 | $1,329 |
| Lamotrigine | 43 | $1,324 |
| Bupropion XlBupropion Hcl | 49 | $1,071 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 41 | $819 |
| Trazodone Hcl | 84 | $752 |
| Sertraline Hcl | 78 | $628 |
| Paroxetine Hcl | 21 | $425 |
| Lithium Carbonate | 18 | $317 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $236 |
| Aripiprazole | 12 | $104 |
| Alprazolam | 11 | $102 |
| Lithium Carbonate ErLithium Carbonate | 17 | $93 |
| Clonazepam | 23 | $84 |
| Duloxetine Hcl | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $15 | $62878 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 900 psychiatry providers in Georgia.
Other psychiatry in Atlanta
- David PurselleAtlanta$307K
- Michael BurkeAtlanta$217K
- Bryon EvansAtlanta$211K
- Kerry ResslerAtlanta$196K
- Patricio Riva PosseAtlanta$122K
- Ray HorwitzAtlanta$64K
- Boadie DunlopAtlanta$61K
- Zohaib HaqueAtlanta$49K
- Raymond KotwickiAtlanta$44K
- Dwight OwensAtlanta$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.